Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial

BACKGROUND: The appropriate age range for breast cancer screening remains a matter of debate. We aimed to estimate the effect of mammographic screening at ages 40–48 years on breast cancer mortality. METHODS: We did a randomised, controlled trial involving 23 breast screening units across Great Brit...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Lancet Oncol
Päätekijät: Duffy, Stephen W, Vulkan, Daniel, Cuckle, Howard, Parmar, Dharmishta, Sheikh, Shama, Smith, Robert A, Evans, Andrew, Blyuss, Oleg, Johns, Louise, Ellis, Ian O, Myles, Jonathan, Sasieni, Peter D, Moss, Sue M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Lancet Pub. Group 2020
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7491203/
https://ncbi.nlm.nih.gov/pubmed/32800099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(20)30398-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia